Letter: Levodopa as a treatment of obesity.
D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos; D014839:Vomiting / Q000139:chemically induced
D010919:Placebos; D004295:Dihydroxyphenylalanine